CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Mellion Michelle L SVP, Clinical Development | Sale 10b5-1 | −1,411 | $18.00 | $25K | 0 |
| 2024-06-06 | Mellion Michelle L SVP, Clinical Development | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,411 | 91,344 | ||
| 2024-06-05 | Mellion Michelle L SVP, Clinical Development | Option exercise 10b5-1 | +7,245 | $10.21 | $74K | 7,245 |
| 2024-06-05 | Mellion Michelle L SVP, Clinical Development | Sale 10b5-1 | −7,245 | $18.09 | $131K | 0 |
| 2024-06-05 | Mellion Michelle L SVP, Clinical Development | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,245 | 92,755 | ||
| 2024-05-17 | Svenstrup Niels SVP, Chem. Mfg & Controls | Sale | −10,000 | $13.41 | $134K | 0 |
| 2024-03-01 | Svenstrup Niels SVP, Chem. Mfg & Controls | Grant or award · Stock Option (Right to Buy) | +83,000 | 83,000 | ||
| 2024-03-01 | McArthur James G President and CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-03-01 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2024-03-01 | Mellion Michelle L SVP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +83,000 | 83,000 | ||
| 2024-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +2,557,593 | $10.64 | $27.2M | 9,179,273 |
| 2024-01-15 | DeLena Mary Beth General Counsel | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-11-30 | McArthur James G President and CEO | Purchase | +1,694 | $4.17 | $7K | 1,694 |
| 2023-11-10 | Mayer Howard Director | Grant or award · Stock Option (Right to Buy) | +22,686 | 22,686 | ||
| 2023-06-22 | Ashton Christopher Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-22 | Resnick Joshua Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-22 | KEATING LAURIE Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-22 | HENSON HEIDI Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2023-06-22 | Dable Habib J Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-06-08 | McArthur James G President and CEO | Option exercise 10b5-1 | +2,381 | $2.71 | $6K | 2,381 |
Page 7 of 11 · 211 trades